$31.95
0.05 (+0.16%)
Bristol-Myers Squibb Co. (NYSE:BMY)
CAPS Rating:
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.
Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.